Results 261 to 270 of about 65,548 (298)

Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine. [PDF]

open access: yesJ Nanobiotechnology
Zhao Y   +13 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Intranasal Naloxone Administration

New England Journal of Medicine, 2021
Intranasal Administration of Naloxone Intranasal naloxone is used to treat patients with respiratory and central nervous system depression that is known or suspected to be caused by an opioid overd...
Arne K, Skulberg   +2 more
openaire   +4 more sources

Concentrated Midazolam for Intranasal Administration

Pediatric Emergency Care, 2011
N ...
Calligaris, Lorenzo   +5 more
openaire   +2 more sources

Intranasal Administration of Influenza Vaccines

BioDrugs, 2000
AbstractThis review article focuses on intranasal immunisation against influenza,although it also encompasses antigen uptake and processing in the nasopharyngealpassages, host defence from influenza and current influenza vaccination practices.Improvement of current vaccination strategies is clearly required; current proceduresinvolve repeated annual ...
J E, Eyles, E D, Williamson, H O, Alpar
openaire   +2 more sources

Intranasal estradiol administration to oophorectomized women

European Journal of Obstetrics & Gynecology and Reproductive Biology, 1991
An open, dose-finding study into the effects of a new intranasal 17 beta-estradiol formulation using dimethyl-beta-cyclodextrin as a solubilizer was conducted in nine hysterectomized and oophorectomized patients with symptoms of estrogen deficiency. After nasal delivery of 0.34 mg estradiol in three patients, concentration-time curves of estradiol in ...
W A, Hermens   +5 more
openaire   +2 more sources

Intranasal Administration

Journal of the American College of Toxicology, 1994
The intranasal route has gained increased popularity in the pharmaceutical industry in recent years, particularly because of the number of new peptide therapeutic agents. This has led to a corresponding increase in both interest in and performance of toxicity (or as they are called in the pharmaceutical industry, safety assessment) studies by this ...
openaire   +1 more source

Efficacy of intranasal administration of neostigmine in myasthenic patients

Journal of Neurology, 1992
The efficacy of intranasally administered neostigmine was tested in 22 patients with generalized myasthenia gravis (MG). Topical therapy to the highly vascularized oropharynx proved to be quickly effective in 5-15 min both clinically and electrophysiologically.
A, Sghirlanzoni   +8 more
openaire   +2 more sources

Intranasal administration of deferoxamine to iron overloaded patients

The American Journal of the Medical Sciences, 1989
We examined the effect of intranasal administration of deferoxamine on iron excretion in seven patients with iron overload secondary to chronic transfusion therapy. Deferoxamine was administered in doses of 0.75 to 3.0 gm given over 12 hours in a variety of dosing schedules.
G S, Gordon   +3 more
openaire   +2 more sources

The Intranasal Route as an Alternative Method of Medication Administration

Critical Care Nurse, 2018
Intranasal drug administration is a less invasive method of drug delivery that is easily accessible for adult and pediatric patients. Medications administered by the intranasal route have efficacy comparable to intravenous administration and typically have superior efficacy to subcutaneous or intramuscular routes.
Calvin, Tucker, Lyn, Tucker, Kyle, Brown
openaire   +2 more sources

Home - About - Disclaimer - Privacy